• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中瓦博格效应的代谢特征:营养转运蛋白与分解代谢/合成代谢途径之间促进肿瘤生长的有效且必要的相互作用

Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth.

作者信息

Mathew Marilyn, Nguyen Nhi T, Bhutia Yangzom D, Sivaprakasam Sathish, Ganapathy Vadivel

机构信息

Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

出版信息

Cancers (Basel). 2024 Jan 24;16(3):504. doi: 10.3390/cancers16030504.

DOI:10.3390/cancers16030504
PMID:38339256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10854907/
Abstract

Aerobic glycolysis in cancer cells, originally observed by Warburg 100 years ago, which involves the production of lactate as the end product of glucose breakdown even in the presence of adequate oxygen, is the foundation for the current interest in the cancer-cell-specific reprograming of metabolic pathways. The renewed interest in cancer cell metabolism has now gone well beyond the original Warburg effect related to glycolysis to other metabolic pathways that include amino acid metabolism, one-carbon metabolism, the pentose phosphate pathway, nucleotide synthesis, antioxidant machinery, etc. Since glucose and amino acids constitute the primary nutrients that fuel the altered metabolic pathways in cancer cells, the transporters that mediate the transfer of these nutrients and their metabolites not only across the plasma membrane but also across the mitochondrial and lysosomal membranes have become an integral component of the expansion of the Warburg effect. In this review, we focus on the interplay between these transporters and metabolic pathways that facilitates metabolic reprogramming, which has become a hallmark of cancer cells. The beneficial outcome of this recent understanding of the unique metabolic signature surrounding the Warburg effect is the identification of novel drug targets for the development of a new generation of therapeutics to treat cancer.

摘要

癌细胞中的有氧糖酵解,最初是由瓦尔堡在100年前观察到的,即使在有充足氧气的情况下,它也会将乳酸作为葡萄糖分解的最终产物产生,这是当前对癌细胞特异性代谢途径重编程产生兴趣的基础。目前对癌细胞代谢的重新关注已经远远超出了最初与糖酵解相关的瓦尔堡效应,扩展到了其他代谢途径,包括氨基酸代谢、一碳代谢、磷酸戊糖途径、核苷酸合成、抗氧化机制等。由于葡萄糖和氨基酸是为癌细胞中改变的代谢途径提供燃料的主要营养物质,介导这些营养物质及其代谢产物不仅跨质膜,而且跨线粒体膜和溶酶体膜转运的转运蛋白,已成为瓦尔堡效应扩展的一个不可或缺的组成部分。在这篇综述中,我们重点关注这些转运蛋白与促进代谢重编程的代谢途径之间的相互作用,而代谢重编程已成为癌细胞的一个标志。最近对围绕瓦尔堡效应的独特代谢特征的理解所带来的有益成果,是确定了用于开发新一代癌症治疗药物的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/3e08e9813b73/cancers-16-00504-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/7d95e79bba29/cancers-16-00504-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/9fb6e12df497/cancers-16-00504-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/4df5c889a9ee/cancers-16-00504-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/3e08e9813b73/cancers-16-00504-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/7d95e79bba29/cancers-16-00504-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/9fb6e12df497/cancers-16-00504-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/4df5c889a9ee/cancers-16-00504-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2064/10854907/3e08e9813b73/cancers-16-00504-g004.jpg

相似文献

1
Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth.癌症中瓦博格效应的代谢特征:营养转运蛋白与分解代谢/合成代谢途径之间促进肿瘤生长的有效且必要的相互作用
Cancers (Basel). 2024 Jan 24;16(3):504. doi: 10.3390/cancers16030504.
2
Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.癌细胞中的代谢重编程:糖酵解、谷氨酰胺分解以及Bcl-2蛋白作为癌症的新型治疗靶点
World J Surg Oncol. 2016 Jan 20;14(1):15. doi: 10.1186/s12957-016-0769-9.
3
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.瓦堡效应:代谢重编程的必要部分,也是癌症进展的主要贡献者。
Int J Radiat Biol. 2019 Jul;95(7):912-919. doi: 10.1080/09553002.2019.1589653. Epub 2019 Mar 22.
4
Revisiting the Warburg effect: historical dogma versus current understanding.重新审视瓦堡效应:历史定论与当前认识。
J Physiol. 2021 Mar;599(6):1745-1757. doi: 10.1113/JP278810. Epub 2021 Jan 4.
5
Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.乳酸和乳酸转运蛋白作为维持瓦博格效应的关键因素。
Adv Exp Med Biol. 2020;1219:51-74. doi: 10.1007/978-3-030-34025-4_3.
6
Glutamine metabolism in breast cancer and possible therapeutic targets.乳腺癌中的谷氨酰胺代谢及潜在治疗靶点。
Biochem Pharmacol. 2023 Apr;210:115464. doi: 10.1016/j.bcp.2023.115464. Epub 2023 Feb 26.
7
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.SLC6A14和SLC38A5驱动癌症中的谷氨酰胺分解和丝氨酸-甘氨酸-一碳途径。
Pharmaceuticals (Basel). 2021 Mar 4;14(3):216. doi: 10.3390/ph14030216.
8
From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy.从瓦伯格效应到逆瓦伯格效应;抗癌治疗的新视野。
Med Hypotheses. 2020 Nov;144:110216. doi: 10.1016/j.mehy.2020.110216. Epub 2020 Aug 26.
9
Correction: Mathew et al. Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth. 2024, , 504.更正:马修等人。癌症中瓦伯格效应的代谢特征:营养转运蛋白与分解代谢/合成代谢途径之间促进肿瘤生长的有效且必然的相互作用。2024年,,504。 (注:原文中“2024, , 504”表述似乎不太完整或有误)
Cancers (Basel). 2024 Apr 24;16(9):1627. doi: 10.3390/cancers16091627.
10
Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.重新审视肿瘤细胞中的瓦博格效应对代谢控制和癌症重编程的影响。
Int J Mol Sci. 2022 Sep 2;23(17):10037. doi: 10.3390/ijms231710037.

引用本文的文献

1
Bioinformatics analysis of laryngeal squamous cell carcinoma based on the high infection rate of HPV in Northwest China.基于中国西北地区人乳头瘤病毒高感染率的喉鳞状细胞癌生物信息学分析
PeerJ. 2025 Aug 11;13:e19851. doi: 10.7717/peerj.19851. eCollection 2025.
2
Impact of gastrointestinal dysbiosis on tryptophan metabolism and neurological cancer progression.胃肠道生态失调对色氨酸代谢及神经肿瘤进展的影响。
Med Oncol. 2025 Aug 6;42(9):412. doi: 10.1007/s12032-025-02972-2.
3
Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesis.

本文引用的文献

1
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4.乳酸受体 GPR81 通过调节细胞外基质特性和 Notch 配体 DLL4 驱动乳腺癌的生长和侵袭。
BMC Cancer. 2023 Nov 22;23(1):1136. doi: 10.1186/s12885-023-11631-6.
2
Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis.Sigma 受体:铁/血红素稳态和铁死亡的新型调节剂。
Int J Mol Sci. 2023 Sep 28;24(19):14672. doi: 10.3390/ijms241914672.
3
Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer.
致癌力量和肿瘤抑制力量汇聚于祖细胞精心构建的生态位,以塑造早期肿瘤发生。
bioRxiv. 2025 Jun 12:2025.06.10.656791. doi: 10.1101/2025.06.10.656791.
4
Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma.早期肺腺癌新型生物标志物特征的基因表达分析与验证
Biomolecules. 2025 May 31;15(6):803. doi: 10.3390/biom15060803.
5
Unveiling GBE1 as a hypoxia-related prognostic gene with significant impact on immune cell infiltration in HER2-enriched breast cancer.揭示GBE1作为一种与缺氧相关的预后基因,对HER2富集型乳腺癌中的免疫细胞浸润有显著影响。
Discov Oncol. 2025 Jun 1;16(1):975. doi: 10.1007/s12672-025-02826-3.
6
Fumarate hydratase in cancer research: scientific trends and findings over 22 years.癌症研究中的富马酸水合酶:22年的科学趋势与研究发现
Discov Oncol. 2025 May 29;16(1):949. doi: 10.1007/s12672-025-02312-w.
7
Identification and Validation of a Novel Lactylation-related Gene Signature to Predict the Prognosis of Endometrial Cancer.一种用于预测子宫内膜癌预后的新型乳酸化相关基因特征的鉴定与验证
Discov Oncol. 2025 May 22;16(1):862. doi: 10.1007/s12672-025-02663-4.
8
Not Just an Alternative Energy Source: Diverse Biological Functions of Ketone Bodies and Relevance of HMGCS2 to Health and Disease.不仅仅是一种替代能源:酮体的多种生物学功能以及HMGCS2与健康和疾病的相关性
Biomolecules. 2025 Apr 14;15(4):580. doi: 10.3390/biom15040580.
9
Beyond Genetics: Exploring Lifestyle, Microbiome, and Social Determinants in Oral Cancer Development.超越遗传学:探索口腔癌发生中的生活方式、微生物群和社会决定因素。
Cancers (Basel). 2025 Mar 25;17(7):1094. doi: 10.3390/cancers17071094.
10
Emerging Role of Hypoxia-Inducible Factors (HIFs) in Modulating Autophagy: Perspectives on Cancer Therapy.缺氧诱导因子(HIFs)在调节自噬中的新兴作用:癌症治疗的前景
Int J Mol Sci. 2025 Feb 19;26(4):1752. doi: 10.3390/ijms26041752.
氨基酸转运蛋白 SLC38A5 是胰腺癌的肿瘤促进剂和新的治疗靶点。
Sci Rep. 2023 Oct 6;13(1):16863. doi: 10.1038/s41598-023-43983-1.
4
Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment.人类单羧酸转运蛋白1(hMCT1)和4(hMCT4)在肿瘤细胞及肿瘤微环境中的作用
Cancer Manag Res. 2023 Sep 4;15:957-975. doi: 10.2147/CMAR.S421771. eCollection 2023.
5
Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.苹果酸酶 2 维持的细胞氧化还原稳态对于 MYC 驱动的 T 细胞淋巴瘤发生是必不可少的。
Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2217869120. doi: 10.1073/pnas.2217869120. Epub 2023 May 30.
6
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells.癌细胞对蛋氨酸的消耗导致 CD4 T 细胞中 PD-1 表达的逐渐上调。
Nat Commun. 2023 May 5;14(1):2593. doi: 10.1038/s41467-023-38316-9.
7
Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies.促癌酶脂肪酸合酶在癌症特征中的作用:抗癌治疗的一个有前景的靶点。
Oncogenesis. 2023 Mar 18;12(1):16. doi: 10.1038/s41389-023-00460-8.
8
Amino acid sensing and lysosomal signaling complexes.氨基酸感应和溶酶体信号复合物。
Curr Opin Struct Biol. 2023 Apr;79:102544. doi: 10.1016/j.sbi.2023.102544. Epub 2023 Feb 16.
9
Nutrient transporters: connecting cancer metabolism to therapeutic opportunities.营养转运蛋白:将癌症代谢与治疗机会联系起来。
Oncogene. 2023 Mar;42(10):711-724. doi: 10.1038/s41388-023-02593-x. Epub 2023 Feb 4.
10
SLC11A2: a promising biomarker and therapeutic target in ovarian cancer.SLC11A2:卵巢癌有前景的生物标志物和治疗靶点。
Sci Rep. 2023 Jan 20;13(1):1132. doi: 10.1038/s41598-022-26789-5.